|
 |
Home 
|
 |
 |
DRUG ATTITUDE INVENTORY(DAI-30, DAI-10)
|
Back to Psychiatric Assessment Tools
If you would like to use the DAI-10 or obtain further information please contact:
Dr. A. G. Awad
Humber River Regional Hospital
2175 Keele Street, Ste. 243A
Toronto, ON M6M 3Z4
Tel.: (416) 658-2008
Fax: (416) 658-2015
E-mail: [email protected]
DRUG ATTITUDE INVENTORY (DAI-10)
(Shortened Version)
|
1.
|
For me, the good things about medication outweigh the bad.
|
F
|
T
|
|
2.
|
I feel weird, like a zombie, on medication.
|
F
|
T
|
|
3.
|
I take medications of my own free choice.
|
F
|
T
|
|
4.
|
Medications make me feel more relaxed.
|
F
|
T
|
|
5.
|
Medication makes me feel tired and sluggish.
|
F
|
T
|
|
6.
|
I take medication only when I am sick.
|
F
|
T
|
|
7.
|
I feel more normal on medication.
|
F
|
T
|
|
8.
|
It is unnatural for my mind and body to be controlled by medications.
|
F
|
T
|
|
9.
|
My thoughts are clearer on medication.
|
F
|
T
|
|
10.
|
By staying on medications, I can prevent getting sick.
|
F
|
T
|
If you have any further comments about the medication or this questionnaire, please write them below or overleaf.
DO NOT WRITE BELOW THIS LINE
_________________________________________________________
CB ___________ PC ____________ ____________
VPCAT ___________ ____________ ____________
Drug Attitude Inventory (DAI-30)
What is the technique?
The DAI-30 is a 30-item self-report inventory that refocuses on the subjective effects of neuroleptic medications in-patients with schizophrenia. The scale was developed to measure subjective response to medication in an effort to obtain a more complete understanding of factors influencing medication compliance schizophrenia patients. Clinicians have frequently reported changes in subjective state concomitant with neuroleptic dosing. This inventory is designed to measure schizophrenia patients subjective responses to medications as well as values and attitudes toward illness and health.
Good internal consistency has been demonstrated, and a brief 10-item scale that focuses on medication effects has also been found useful. High test-retest reliability has been demonstrated over the short-term, and a high correlation with medication compliance and treatment outcome has been reported.
The scale has been translated into several foreign languages, although complete validation information is not available for some of these versions.
What are the primary sources of information about the technique?
Hogan T.P., Awad A.G., Eastwood R: A Self-report Predictive of Drug Compliance in Schizophrenia: Reliability and Discriminative Ability Psychological Medicine 1983, 13:177-183.
Hogan T.P., Awad A.G.: Subjective Response to Neuroleptics and Outcome in Schizophrenia: A Re-examination of Two Measures. Psychological Medicine 1992, 23:347-352.
Awad A.G. (1993): Subjective Response to Neuroleptics in Schizophrenia. Schizophrenia Bulletin 19:609-618.
Awad A.G., Hogan T.P., Voruganti L.N.P. and Heslegrave R.J.: Patients Subjective Experiences on Antipsychotic Medications: Implications for Outcome and Quality of Life. Int. Clin. Psychopharmacology 1995, 10, (Suppl. 3): 123-133.
Awad A.G., Voruganti L.N.P., Heslegrave R.J. A Conceptual Model of Quality of Life in Schizophrenia: Description and Preliminary Clinical Validation. Quality of Life Research, 6: 21-26, 1997.
Voruganti L.N.P., Heslegrave R.J., Awad A.G.: Neuroleptic Dysphoria May be the Missing Link Between Schizophrenia and Substance Abuse. Journal of Nervous and Mental Diseases. 185: 463-465, 1997.
What are the costs and levels of effort required to use the technique?
Permission to use the scale is usually granted to clinical investigators for the purpose of a single research project, without a fee. A fee will be charged for use in industry-related clinical trials. The scale is simple and can be self-administered with minimal supervision.
How can the scale be obtained?
Permission to use the scale as well as additional information on the instrument can be obtained from:
A.G. Awad, M.B., B.Ch., Ph.D., F.R.C.P.(C)
Chief of Psychiatry & Physician Director
Humber River Regional Hospital
2175 Keele Street, Ste. 243A
Toronto, ON M6M 3Z4
Tel.: (416) 658-2008
Fax: (416) 658-2015
Comments from Developers:
The primary advantage of this inventory is that it is simple, easy to administer and its psychometrics well-known. Patients typically do not find the inventory intrusive or difficult to understand. There is good evidence that scores on the scale can predict medication compliance and treatment outcome in patients with schizophrenia.
A. George Awad, M.B., Ph.D.
|
|
Search
Quick Links
Page Tools
|
|
| |
|
 |
